Gadolinium-based contrast agents and nephrotoxicity in patients undergoing coronary artery procedures [2]

Catheterization and Cardiovascular Interventions

Volumn 68, Issue 5, 2006, Pages 813-

  Briguori, Carlo ^a,b  

^a VITA SALUTE SAN RAFFAELE UNIVERSITY   (Italy)

^b Clinica Mediterranea   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CONTRAST MEDIUM; GADOLINIUM;

ANGIOCARDIOGRAPHY; BODY WEIGHT; CLINICAL PRACTICE; CONTRAST ENHANCEMENT; CONTRAST NEPHROPATHY; CONTRAST RADIOGRAPHY; CORONARY ARTERY DISEASE; DRUG MEGADOSE; HUMAN; LETTER; NEPHROTOXICITY; PRACTICE GUIDELINE;

EID: 33750891876     PISSN: 15221946     EISSN: 1522726X     Source Type: Journal    
DOI: 10.1002/ccd.20928     Document Type: Letter

References (5)

1. Briguori C, Colombo A, Airoldi F, et al. Gadolinium-based contrast agents and nephrotoxicity in patients undergoing coronary artery procedures. Catheter Cardiovasc Interv 2006;67:175-180.
2. Morcos SK, Thomsen HS, Webb JA, et al. Contrast-media-induced nephrotoxicity: A consensus report. Eur Radiol 1999;9:1602-1613.
3. Thomsen HS, Almén T, Morcos SK, Members of Contrast Media Safety Committee of European Society of Urogenital Radiology (ESUR). Gadolinium-containing contrast media for radiographic examinations: A position paper. Eur Radiol 2002;12:2600-2605.
4. Nyman U, Elmståhl B, Leander P, Nilsson M, Golman K, Almèn T. Are gadolinium-based contrast media really safer than iodinated media for digital subtraction angiography in patients with azotemia? Radiology 2002;223:311-318.
5. Erley CM, Bader BD, Berger ED, Tuncel N, Winkler S, Tepe G, Risler T, Duda S. Gadolinium-based contrast media compared with iodinated media for digital subtraction angiography in azotaemic patients. Nephrol Dial Transplant 2004;19:2526-2531.